Erhardt A - Search Results

1

Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B.

Heintges T, Petry W, Kaldewey M, Erhardt A, Wend UC, Gerlich WH, Niederau C, Häussinger D. Heintges T, et al. Among authors: erhardt a. Dig Dis Sci. 2001 Apr;46(4):901-6. doi: 10.1023/a:1010785325067. Dig Dis Sci. 2001. PMID: 11330431

2

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.

Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, Heintges T, Häussinger D. Erhardt A, et al. Liver Int. 2006 Sep;26(7):805-10. doi: 10.1111/j.1478-3231.2006.01279.x. Liver Int. 2006. PMID: 16911462 Clinical Trial.

3

Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs.

Erhardt A, Behlen-Wilm U, Adams O, Donner A, Heintges T, Häussinger D. Erhardt A, et al. Dig Dis Sci. 2003 May;48(5):921-5. doi: 10.1023/a:1023051613300. Dig Dis Sci. 2003. PMID: 12772791 Clinical Trial.

4

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B.

Erhardt A, Reineke U, Blondin D, Gerlich WH, Adams O, Heintges T, Niederau C, Häussinger D. Erhardt A, et al. Hepatology. 2000 Mar;31(3):716-25. doi: 10.1002/hep.510310323. Hepatology. 2000. PMID: 10706563 Clinical Trial.

5

[Antiviral therapy of hepatitis C].

Erhardt A, Petry W, Ebel M, Jablonowski H, Heintges T, Häussinger D. Erhardt A, et al. Z Gastroenterol. 2000 Mar;38(3):259-69. doi: 10.1055/s-2000-14867. Z Gastroenterol. 2000. PMID: 10768250 Review. German.

6

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D.

Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, Häussinger D. Erhardt A, et al. Gut. 2005 Jul;54(7):1009-13. doi: 10.1136/gut.2004.060327. Gut. 2005. PMID: 15951551 Free PMC article.

7

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W, Häussinger D. Niederau C, et al. Among authors: erhardt a. Hepatology. 1998 Dec;28(6):1687-95. doi: 10.1002/hep.510280632. Hepatology. 1998. PMID: 9828236

8

[New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].

Petry W, Erhardt A, Heintges T, Häussinger D. Petry W, et al. Among authors: erhardt a. Z Gastroenterol. 2000 Jan;38(1):77-87. doi: 10.1055/s-2000-14851. Z Gastroenterol. 2000. PMID: 10689749 Review. German.

9

Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection.

Sagir A, Heintges T, Akyazi Z, Oette M, Erhardt A, Häussinger D. Sagir A, et al. Among authors: erhardt a. Liver Int. 2007 Sep;27(7):954-9. doi: 10.1111/j.1478-3231.2007.01508.x. Liver Int. 2007. PMID: 17696934

10

Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase.

Tessmann K, Erhardt A, Häussinger D, Heintges T. Tessmann K, et al. Among authors: erhardt a. J Virol Methods. 2002 May;103(1):75-88. doi: 10.1016/s0166-0934(02)00017-4. J Virol Methods. 2002. PMID: 11906735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters